Ronan Kelly

Ronan M. Kelly received his Ph.D. from the University of Groningen, the Netherlands, where he focused on protein engineering of carbohydrate-modifying enzymes. Shortly after, Ronan joined N.I.B.R.T, Dublin, where he explored CHO cell glycoengineering strategies to enhance the effector function of IgG1 mAbs. In his time at Lilly, Ronan has held many roles including a position in technical services in mAb manufacturing and cell line engineering in the Bioprocess, Research and Development group. More recently, Ronan leads a team in Biotechnology Discovery Research at Lilly, focused on the expression and purification of complex recombinant proteins from both mammalian and bacterial systems.

Appearances